NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Ruhan Gene Tech

Ruhan Gene Tech

Private
ShenzhenHealthcare & Life Scienceshttps://www.rhgenetech.com/

Last Round

Angel

Sep 6, 2021

Company Overview

Ruhan Gene Tech is a biotechnology company that develops fourth-generation gene sequencing equipment and nanopore-based virus detection systems for medical and public health applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

nanopore sequencingpathogen detectiongenomic sequencingvirus identificationclinical diagnosticsepidemic preventionPOCTpoint-of-care testingrapid testingfourth-generation sequencingportable diagnosticsbiosurveillancebiotech hardwarebase-callingmacromolecule detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ruhan Gene Tech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ruhan Gene Tech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AngelSep 6, 2021
SeedDec 1, 2019
View all Funding Rounds

Ruhan Gene Tech Investors

Notable investors and investment history

InvestorRounds
Shenzhen Leaguer Venture CapitalAngel
Hengbang CapitalSeed
View all Investors

Ruhan Gene Tech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ruhan Gene Tech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ruhan Gene Tech's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Year Founded2019
Last FundingSep 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




ProductsSecondary Data & TradingCaplight MarketPrice™Company DatabaseInvestor DatabaseSourcingAPI & MCP

Use CasesInvestorsEmployees

ResourcesResearch & BlogAboutCareers

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.